These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 17239341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation.
    Regmi A, Fuson T, Yang X, Kays J, Moxham C, Zartler E, Chandrashekhar S, Galvin RJ.
    Bone; 2005 Feb; 36(2):284-91. PubMed ID: 15780954
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms involved in the enhancement of osteoclast formation by enamel matrix derivative.
    Itoh N, Kasai H, Ariyoshi W, Harada E, Yokota M, Nishihara T.
    J Periodontal Res; 2006 Aug; 41(4):273-9. PubMed ID: 16827720
    [Abstract] [Full Text] [Related]

  • 5. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.
    Sasaki H, Yamamoto H, Tominaga K, Masuda K, Kawai T, Teshima-Kondo S, Matsuno K, Yabe-Nishimura C, Rokutan K.
    Free Radic Biol Med; 2009 Jul 15; 47(2):189-99. PubMed ID: 19409483
    [Abstract] [Full Text] [Related]

  • 6. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY, Lin HY, Fong YC, Wu JB, Chen YF, Tsuzuki M, Tang CH.
    Eur J Pharmacol; 2008 Jun 24; 588(1):124-33. PubMed ID: 18495114
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
    Voronov I, Heersche JN, Casper RF, Tenenbaum HC, Manolson MF.
    Biochem Pharmacol; 2005 Jul 15; 70(2):300-7. PubMed ID: 15919055
    [Abstract] [Full Text] [Related]

  • 8. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 9. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y.
    Eur J Immunol; 2008 Jun 13; 38(6):1598-609. PubMed ID: 18421790
    [Abstract] [Full Text] [Related]

  • 10. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
    Chang EJ, Kim HJ, Ha J, Kim HJ, Ryu J, Park KH, Kim UH, Lee ZH, Kim HM, Fisher DE, Kim HH.
    J Cell Sci; 2007 Jan 01; 120(Pt 1):166-76. PubMed ID: 17164294
    [Abstract] [Full Text] [Related]

  • 11. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways.
    Park JY, Bae MA, Cheon HG, Kim SS, Hong JM, Kim TH, Choi JY, Kim SH, Lim J, Choi CH, Shin HI, Kim SY, Park EK.
    Biochem Biophys Res Commun; 2009 Jan 16; 378(3):645-9. PubMed ID: 19059209
    [Abstract] [Full Text] [Related]

  • 12. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T, Hoshino M, Aoki K, Ohya K, Komano Y, Nanki T, Miyasaka N, Umezawa K.
    Arthritis Res Ther; 2007 Jan 16; 9(5):R97. PubMed ID: 17892600
    [Abstract] [Full Text] [Related]

  • 13. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH, Ryu SY, Bae MA, Choi JS, Min YK, Kim SH.
    Food Chem Toxicol; 2008 Nov 16; 46(11):3375-82. PubMed ID: 18786594
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment.
    Bai YD, Yang FS, Xuan K, Bai YX, Wu BL.
    Med Hypotheses; 2008 Aug 16; 71(2):256-8. PubMed ID: 18445511
    [Abstract] [Full Text] [Related]

  • 15. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor.
    Islam S, Hassan F, Tumurkhuu G, Dagvadorj J, Koide N, Naiki Y, Yoshida T, Yokochi T.
    Microbiol Immunol; 2008 Dec 16; 52(12):585-90. PubMed ID: 19120972
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation.
    Kim SN, Kim MH, Kim YS, Ryu SY, Min YK, Kim SH.
    Phytother Res; 2009 Feb 16; 23(2):185-91. PubMed ID: 18690659
    [Abstract] [Full Text] [Related]

  • 17. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways.
    Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, Okamoto K.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):70-9. PubMed ID: 18083161
    [Abstract] [Full Text] [Related]

  • 18. The mechanism of osteoclast differentiation induced by IL-1.
    Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, Kim N.
    J Immunol; 2009 Aug 01; 183(3):1862-70. PubMed ID: 19587010
    [Abstract] [Full Text] [Related]

  • 19. Activated platelets positively regulate RANKL-mediated osteoclast differentiation.
    Weicht B, Maitz P, Kandler B, Fischer MB, Watzek G, Gruber R.
    J Cell Biochem; 2007 Dec 01; 102(5):1300-7. PubMed ID: 17957725
    [Abstract] [Full Text] [Related]

  • 20. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S, Kwan Tat S, Vusio P, Blanchard F, Gallagher J, Ricard-Blum S, Fortun Y, Padrines M, Rédini F, Heymann D.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):460-7. PubMed ID: 16828054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.